A patient-focused, clinical-stage immuno-oncology startup. Our lead candidate, #OS2966, is FDA Orphan Drug Designated for glioblastoma and ovarian cancer.

ID: 279806882

linkhttps://linktr.ee/Oncosynergy calendar_today10-04-2011 02:05:33